Back
Lyra Therapeutics Stock Predictions

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
29
LYRA
Lyra Therapeutics
Last Price:
$10.87
Seasonality Move:
12.18%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaLyra Therapeutics Stock Forecast
-
Over the next 52 weeks, Lyra Therapeutics has on average historically fallen by 45.1% based on the past 5 years of stock performance.
-
Lyra Therapeutics has fallen lower in 5 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Lyra Therapeutics Stock Undervalued?The current Lyra Therapeutics [LYRA] share price is $10.68. The Score for LYRA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
LYRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Lyra Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Lyra Therapeutics has on average historically fallen by 45.1% based on the past 5 years of stock performance.
Lyra Therapeutics Stock Rating
Sell
29
Lyra Therapeutics (LYRA)
is a Sell
Is Lyra Therapeutics overpriced?
-
Lyra Therapeutics has fallen lower in 5 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Lyra Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
lyratherapeutics.com
52-Week Data
52-Week High:
37.50
52-Week Low:
3.81
Prediction Charts
Market Cap:
14.2M
Price in USD:
10.68
Volume:
117.6K
Beta:
-0.01
Technical Analysis
SMA50:
8.14
SMA100:
8.48
SMA200:
9.95
52-Wk Change:
-17.47%
Stock Predictions
-
Is Lyra Therapeutics stock public?Yes, Lyra Therapeutics is a publicly traded company.
-
What is the Lyra Therapeutics stock quote today?The Lyra Therapeutics stock price is 10.68 USD today.
-
How to buy Lyra Therapeutics stock online?You can buy Lyra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-30 | 5.01 | 4.93 | 5.34 | 4.60 |
Jun-2 | 29.01 | 20.25 | 37.50 | 8.65 |
Jun-3 | 22.70 | 27.58 | 34.00 | 22.51 |
Jun-4 | 25.61 | 22.82 | 26.04 | 22.27 |
Jun-5 | 22.25 | 25.33 | 27.42 | 22.22 |
Jun-6 | 25.02 | 24.28 | 26.50 | 23.85 |
Jun-9 | 22.76 | 18.42 | 23.83 | 18.10 |
Jun-10 | 17.53 | 15.50 | 19.45 | 15.33 |
Jun-11 | 14.88 | 13.50 | 14.91 | 12.53 |
Jun-12 | 13.33 | 11.85 | 13.50 | 11.51 |
Jun-13 | 11.49 | 11.34 | 12.50 | 10.98 |
Jun-16 | 11.18 | 11.33 | 12.17 | 10.56 |
Jun-17 | 11.33 | 10.28 | 11.64 | 10.27 |
Jun-18 | 10.21 | 10.68 | 11.06 | 9.81 |
Lyra Therapeutics Earnings
Lyra Therapeutics Earnings Report: Per Share Lyra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Lyra Therapeutics Forecast Revenue Growth
Lyra Therapeutics Stock Analysis: Historical quarterly revenues per share for Lyra Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.
* Lyra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.